Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,845 | 352 | 99.4% |
| Education | $31.52 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,023 | 72 | $0 (2021) |
| Lilly USA, LLC | $560.19 | 48 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $539.48 | 44 | $0 (2021) |
| GlaxoSmithKline, LLC. | $509.79 | 36 | $0 (2020) |
| PFIZER INC. | $323.55 | 32 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $247.24 | 9 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $201.66 | 14 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $125.80 | 9 | $0 (2019) |
| ARBOR PHARMACEUTICALS, INC. | $122.89 | 9 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $121.35 | 10 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $389.07 | 20 | Novo Nordisk Inc ($152.56) |
| 2020 | $780.55 | 51 | Novo Nordisk Inc ($165.23) |
| 2019 | $960.57 | 66 | Novo Nordisk Inc ($163.91) |
| 2018 | $1,283 | 99 | Novo Nordisk Inc ($226.47) |
| 2017 | $1,463 | 120 | Novo Nordisk Inc ($314.44) |
All Payment Transactions
356 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/23/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: Diabetes | ||||||
| 06/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Diabetes | ||||||
| 06/16/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Cardiovascular | ||||||
| 06/16/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Gastroenterology | ||||||
| 06/04/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Obesity | ||||||
| 05/19/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Cardiovascular | ||||||
| 05/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/05/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Iron Deficiency Anemia | ||||||
| 04/29/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Gastroenterology | ||||||
| 04/28/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Diabetes | ||||||
| 04/20/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Cardiovascular | ||||||
| 04/08/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Iron Deficiency Anemia | ||||||
| 04/06/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/01/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $13.57 | General |
| Category: Neurology | ||||||
| 03/25/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: IMMUNOLOGY | ||||||
| 03/17/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/01/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/09/2021 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/14/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/07/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: PRIMARY CARE | ||||||
| 12/22/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/10/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Cardiovascular | ||||||
| 12/08/2020 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: PRIMARY CARE | ||||||
| 11/19/2020 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/17/2020 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 12 | 808 | 1,064 | $137,450 | $49,969 |
| 2020 | 22 | 1,719 | 2,601 | $310,482 | $108,693 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 173 | 268 | $62,525 | $19,504 | 31.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 96 | 96 | $23,904 | $12,964 | 54.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 136 | 176 | $27,858 | $8,404 | 30.2% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 12 | 13 | $6,561 | $2,960 | 45.1% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 18 | 19 | $6,730 | $2,907 | 43.2% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 14 | 18 | $3,072 | $1,003 | 32.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 129 | 161 | $3,059 | $995.19 | 32.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 169 | 239 | $1,673 | $714.38 | 42.7% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 13 | 13 | $1,313 | $312.64 | 23.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 14 | $504.00 | $133.21 | 26.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 22 | 26 | $104.00 | $58.50 | 56.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 12 | 21 | $147.00 | $12.59 | 8.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 282 | 600 | $139,800 | $41,997 | 30.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 213 | 213 | $53,037 | $25,056 | 47.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 259 | 377 | $59,566 | $16,487 | 27.7% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 36 | 37 | $12,987 | $5,580 | 43.0% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 22 | 22 | $10,890 | $4,278 | 39.3% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 23 | 23 | $3,105 | $2,721 | 87.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 109 | 117 | $5,475 | $1,955 | 35.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 310 | 627 | $4,389 | $1,868 | 42.6% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 75 | 80 | $1,852 | $1,552 | 83.8% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 20 | 33 | $4,989 | $1,550 | 31.1% |
| 90674 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 38 | 38 | $1,122 | $1,085 | 96.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 97 | 135 | $2,565 | $911.30 | 35.5% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 17 | 19 | $2,147 | $778.59 | 36.3% |
About Dr. William Baker, MD
Dr. William Baker, MD is a Internal Medicine healthcare provider based in Abingdon, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124196787.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Baker, MD has received a total of $4,876 in payments from pharmaceutical and medical device companies, with $389.07 received in 2021. These payments were reported across 356 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,845).
As a Medicare-enrolled provider, Baker has provided services to 2,527 Medicare beneficiaries, totaling 3,665 services with total Medicare billing of $158,662. Data is available for 2 years (2020–2021), covering 34 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Abingdon, VA
- Active Since 12/01/2006
- Last Updated 01/26/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1124196787
Products in Payments
- XARELTO (Drug) $507.56
- Ozempic (Drug) $462.86
- Victoza (Drug) $262.23
- XIFAXAN (Drug) $257.50
- TRULICITY (Drug) $250.46
- ANORO (Drug) $232.82
- SOLIQUA (Drug) $195.95
- CHANTIX (Drug) $189.20
- Saxenda (Drug) $140.37
- BREO (Drug) $136.91
- JARDIANCE (Drug) $135.40
- LATUDA (Drug) $121.35
- ENTRESTO (Drug) $118.53
- Vascepa (Drug) $103.80
- JANUVIA (Drug) $87.63
- ELIQUIS (Drug) $81.07
- NEXLETOL (Drug) $78.98
- Horizant (Drug) $78.17
- Amitiza (Drug) $74.98
- TRELEGY ELLIPTA (Drug) $69.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Abingdon
Emory Robinette, M.d, M.D
Internal Medicine — Payments: $66,893
Clinton Sutherland, Md, MD
Internal Medicine — Payments: $30,337
Haytham Adada, Md, MD
Internal Medicine — Payments: $10,638
Robert Jones, M.d, M.D
Internal Medicine — Payments: $10,385
Dr. Jonathan Swank, Md, MD
Internal Medicine — Payments: $6,901
Moe Mya, M.d, M.D
Internal Medicine — Payments: $4,505